SEC Filings

Form 6-K
UROGEN PHARMA LTD. filed this Form 6-K on 05/15/2018
Document Outline
Entire Document (1670.3 KB)
Subdocument 1 - 6-K - FORM 6-K
Page 1 - UNITED STATES
Page 2 - INCORPORATION BY REFERENCE
Page 3 - SIGNATURES
Page 4 - EXHIBIT INDEX
Subdocument 2 - EX-99 - EX-99.1
Page 1 - Exhibit 99.1
Page 2 - UROGEN PHARMA LTD.
Page 3 - UROGEN PHARMA LTD.
Page 4 - UROGEN PHARMA LTD.
Page 5 - UROGEN PHARMA LTD.
Page 6 - UROGEN PHARMA LTD.
Page 7 - UROGEN PHARMA LTD.
Page 8 - UROGEN PHARMA LTD.
Page 9 - UROGEN PHARMA LTD.
Subdocument 3 - EX-99 - EX-99.2
Page 1 - Exhibit 99.2
Page 2 - Allergan License Agreement
Page 3 - Research and development expenses
Page 4 - General and administrative expenses
Page 5 - Research and development expenses
Page 6 - Cash flows
Page 7 - Net cash provided by (used in) financing activities
Subdocument 4 - EX-99 - EX-99.3
Page 1 - Exhibit 99.3
Page 2 - First Quarter 2018 Financial Results
Page 3 - UROGEN PHARMA LTD.
Page 4 - UROGEN PHARMA LTD.
Page 5 - UROGEN CONTACT:
XBRL Item - EX-101.INS - XBRL INSTANCE DOCUMENT (What's this?)
XBRL Item - EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA (What's this?)
XBRL Item - EX-101.CAL - XBRL TAXONOMY EXTENSION CALCULATION LINKBASE (What's this?)
XBRL Item - EX-101.DEF - XBRL TAXONOMY EXTENSION DEFINITION LINKBASE (What's this?)
XBRL Item - EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE (What's this?)
XBRL Item - EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE (What's this?)
XBRL Viewer